Rising cases, falling age of diagnosis, and a worsening medicine shortage signal a national health emergency
Iran is confronting a rapidly escalating cancer crisis that has triggered urgent warnings from medical experts and even members of the regime itself. The sharp rise in new cases, the steep drop in age of diagnosis, and the growing difficulty of accessing essential medicine have converged into what specialists describe as “a serious alarm for the future of public health.” The crisis has intensified alongside worsening environmental pollution, declining food quality, the early onset of tobacco use, and chronic failures in health policy.
In one of the strongest official reactions to date, Hossein Emami-Rad, a regime MP from Chenaran, Torghabeh, Shandiz, and Golbahar, called on Masoud Pezeshkian to immediately form a national task force for cancer prevention and control. In his letter, he demanded expanded free screening, improved access to standard medications, and strengthened preventive programs. Drawing on data from the Ministry of Health, he warned that nearly 390 people in Iran are diagnosed with cancer every day and around 200 die—figures he described as equivalent to “a passenger plane crash every day.”
Experts point to a broad spectrum of contributors to this surge: tobacco use, air and water pollution, hazardous agricultural chemicals, unhealthy diets, low physical activity, obesity, stress, and weak preventive policies. Many of these factors, particularly environmental contamination and unsafe development practices, are directly tied to the regime’s long-standing mismanagement, weak regulation, and disregard for environmental standards. Health specialists emphasize that years of unregulated construction, soil and water pollution, and collapsing oversight have turned Iran’s environment into a high-risk cancer landscape.
The speed of this increase has deepened the alarm. Official projections show that within the next fifteen years, Iran will surpass global averages for both cancer incidence and mortality. The Ministry of Health’s Center for Non-Communicable Diseases has projected that by 2040, cancer incidence in Iran will rise 1.9 times compared to 1.5 times globally, while cancer-related deaths will double—significantly higher than the global forecast of a 1.6-fold increase. If today 200 people die of cancer daily, this number could reach 400 by 2040, or 146,000 deaths a year.
Several provinces have already reached critical thresholds. Ardabil, Zanjan, East and West Azerbaijan, Razavi Khorasan, and North Khorasan record the highest rates of gastrointestinal cancers, with more than 30 cases of stomach cancer per 100,000 people—placing them in the “very high” category. Kurdistan, Ilam, Mazandaran, Golestan, Kohgiluyeh and Boyer-Ahmad, Semnan, and Lorestan also fall in high-incidence zones. Gastrointestinal cancers are especially deadly in Iran: they account for 27 percent of all cancer deaths, with stomach cancer alone responsible for 16 percent.
Geographical data from 2020 reinforce the urgency. Yazd, Zanjan, and West Azerbaijan topped overall cancer incidence. Among men, Zanjan, North Khorasan, and Ardabil had the highest stomach cancer rates, while Fars, Yazd, and Tehran recorded the most prostate cancer. Among women, Tehran, Semnan, and Yazd had the highest breast cancer rates, and Semnan, Yazd, and Tehran led in colorectal cancer.
Perhaps the most alarming trend is the drop in age of diagnosis. Mohammad-Esmail Akbari, head of the Cancer Research Center, reported that the average age of cancer onset in Iran is now ten years younger than the global average. With only 5–6 percent of cancers attributed to genetics, he stressed that “95 percent are linked to environment and lifestyle,” highlighting factors such as polluted air, processed foods, contaminated water, chronic stress, and reduced physical activity. Iraj Khosronia, head of the Society of Internal Medicine Specialists, previously noted that “one in five people under 50 is now diagnosed with cancer,” compared to one in ten just a decade earlier.
The declining age is visible across cancer types, including breast cancer, where diagnosis in some cities now occurs as early as age 30. Similar patterns appear in gastrointestinal cancers, and cases among children are rising sharply. Official estimates show around 3,000 children under 15 are diagnosed with cancer annually, mostly with acute lymphoblastic leukemia, brain tumors, kidney cancers, and malignant nervous system tumors. These numbers demonstrate that the crisis extends far beyond adults and reflects deep environmental and structural failures.
Compounding this emergency is Iran’s worsening medicine crisis. Over recent months, many patients have been forced to pay exorbitant prices for essential drugs, while others have turned to counterfeit, smuggled, or unregulated herbal products. Ahmad Aryaeinejad, MP for Malayer, confirmed that soaring costs of medicine and medical visits have pushed some families to abandon treatment entirely. He noted that many patients simply “give up on going to the doctor or taking medication” due to financial pressure.
Medical experts warn that without immediate reforms, cancer mortality will exceed current projections. Some believe that if health policies continue on their current trajectory, cancer could soon overtake cardiovascular disease as Iran’s leading cause of death—a scenario some describe as a coming “cancer tsunami.”
Taken together, the data reveal that the cancer crisis in Iran is not merely a medical challenge. It is the cumulative result of years of policy failure, widening economic inequality, environmental degradation, soaring tobacco use, a collapsing pharmaceutical system, weak preventive programs, and the regime’s persistent neglect of public health. Without urgent structural reform, cancer may become the most devastating health threat facing Iranians in the decade ahead.
